(Q40866381)

24 September 2017

title

High dose cytosine arabinoside (HDARAC) in refractory acute leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498009

7 July 2022

1 reference

1 reference

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

11 June 2023

author name string

S. A. Rudnick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498009

7 July 2022

E. C. Cadman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498009

7 July 2022

R. L. Capizzi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498009

7 July 2022

R. T. Skeel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498009

7 July 2022

J. R. Bertino

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498009

7 July 2022

S. McIntosh

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A498009

7 July 2022

language of work or name

English

0 references

publication date

1 October 1979

1 reference

full work available at URL

24 September 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

11 June 2023

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

11 June 2023

1 reference

24 September 2017

volume

44

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

1189-1193

1 reference

24 September 2017

1

29

1036

Bach

1969

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

The clinical pharmacology of methotrexate.new applications of an old drug

11 June 2023

2

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

Management of adult acute myelogenous leukaemia.

11 June 2023

3

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

Studies on drug resistance—II. Kinase patterns in P815 neoplasms sensitive and resistant to 1-β-d-arabinofuranosylcytosine

11 June 2023

4

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

High remission-induction rate in acute myeloid leukaemia

11 June 2023

5

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

Clinical pharmacology of l-β-D-arabinofuranosyl cytosine

11 June 2023

6

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

11 June 2023

7

29

459

Kessel

1969

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

Separation of 5'-mono-, di- and triphosphates of 1-beta-D-arabinofuranosylcytosine and of 1-beta-D-arabinofuranosyluracil by thin-layer and high pressure liquid chromatography

11 June 2023

8

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

11 June 2023

9

34

1775

Momparler

1974

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

Blastic crisis in chronic granulocytic leukemia: Experience in 39 patients

11 June 2023

15

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

11 June 2023

16

34

392

Wan

1974

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

Acute granulocytic leukemia: treatment of the disease

11 June 2023

17

1 reference

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

https://api.crossref.org/works/10.1002/1097-0142(197910)44:4%3C1189::AID-CNCR2820440404%3E3.0.CO;2-O

11 June 2023

Identifiers

10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO;2-O

1 reference

24 September 2017

1 reference